The NBT® System is a New Therapeutic Device
The Navigated Brain Therapy (NBT®) System is a device that uses navigated transcranial magnetic stimulation (nTMS) for use in stroke rehabilitation. Navigation is achieved by visualizing the electric field (e-field) generated by the TMS coil in a 3D image rendered from the patient’s MRI scan.
Stimulation intensity is calculated from the accurate measurement of brain excitability and the personal resting motor threshold (MT) of each patient. The proven accuracy confirms optimal treatment location for the individual patient, and ensures that stimulation treatment is always repeated at the same location, every time and for every session.
NBT® is currently being tested in a multicenter double-blinded, randomized, and sham-controlled trial. This new stroke therapy combines occupational therapy with nTMS. Called the NICHE trial (Navigated Inhibitory rTMS in Contralesional Hemisphere Evaluation), this study is being conducted at twelve of the top rehabilitation sites in the United States.
The NBT® System is CE-marked to offer patients a personalized treatment patients recovering from stroke as a supplement to conventional rehabilitation.
Nexstim's noninvasive NBS and NBT® Systems are not approved by the Food and Drug Administration for therapy in commercial use in the United States and is available to select physician for investigational use only.